Chiesi Farmaceutici SpA - Product Pipeline Review - 2016

  • ID: 3960479
  • Company Profile
  • 61 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Addex Therapeutics Ltd
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Medgenics, Inc.
  • Toray Industries, Inc.
  • MORE
Chiesi Farmaceutici SpA - Product Pipeline Review - 2016

The report ‘Chiesi Farmaceutici SpA - Product Pipeline Review - 2016’, provides an overview of the Chiesi Farmaceutici SpA’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Chiesi Farmaceutici SpA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Chiesi Farmaceutici SpA
- The report provides overview of Chiesi Farmaceutici SpA including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Chiesi Farmaceutici SpA’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Chiesi Farmaceutici SpA’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Chiesi Farmaceutici SpA’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Chiesi Farmaceutici SpA
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Chiesi Farmaceutici SpA’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Addex Therapeutics Ltd
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Medgenics, Inc.
  • Toray Industries, Inc.
  • MORE
Introduction

Chiesi Farmaceutici SpA Snapshot

Chiesi Farmaceutici SpA Overview

Key Facts

Chiesi Farmaceutici SpA - Research and Development Overview

Key Therapeutic Areas

Chiesi Farmaceutici SpA - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Chiesi Farmaceutici SpA - Pipeline Products Glance

Chiesi Farmaceutici SpA - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Chiesi Farmaceutici SpA - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Chiesi Farmaceutici SpA - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Chiesi Farmaceutici SpA - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

Chiesi Farmaceutici SpA - Drug Profiles

(beclomethasone dipropionate + formoterol fumarate + glycopyrrolate) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

budesonide - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CHF-5633 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CHF-6001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CHF-6297 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

CPD-15 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Drugs for Bronchopulmonary Dysplasia - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

glycopyrrolate - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

melatonin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

meropenem - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Recombinant Enzymes for Rare Diseases - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Recombinant Protein for Neonatal Respiratory Distress Syndrome - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Recombinant Protein to Target NGF for Undisclosed Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit Neutrophil Elastase for Respiratory Diseases - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Target Beta 2 Adrenergic Receptor and Muscarinic Acetylcholine Receptor M3 for Asthma and COPD - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Neonatal Abstinence Syndrome - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

TRP-601 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

velmanase alfa - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Chiesi Farmaceutici SpA - Pipeline Analysis

Chiesi Farmaceutici SpA - Pipeline Products by Target

Chiesi Farmaceutici SpA - Pipeline Products by Route of Administration

Chiesi Farmaceutici SpA - Pipeline Products by Molecule Type

Chiesi Farmaceutici SpA - Pipeline Products by Mechanism of Action

Chiesi Farmaceutici SpA - Dormant Projects

Chiesi Farmaceutici SpA - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

beclomethasone dipropionate SR

carmoterol

indantadol

Porphozym

Chiesi Farmaceutici SpA - Company Statement

Chiesi Farmaceutici SpA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Chiesi Farmaceutici SpA, Key Facts

Chiesi Farmaceutici SpA - Pipeline by Indication, 2016

Chiesi Farmaceutici SpA - Pipeline by Stage of Development, 2016

Chiesi Farmaceutici SpA - Monotherapy Products in Pipeline, 2016

Chiesi Farmaceutici SpA - Combination Treatment Modalities in Pipeline, 2016

Chiesi Farmaceutici SpA - Partnered Products in Pipeline, 2016

Chiesi Farmaceutici SpA - Partnered Products/ Combination Treatment Modalities, 2016

Chiesi Farmaceutici SpA - Out-Licensed Products in Pipeline, 2016

Chiesi Farmaceutici SpA - Out-Licensed Products/ Combination Treatment Modalities, 2016

Chiesi Farmaceutici SpA - Phase III, 2016

Chiesi Farmaceutici SpA - Phase II, 2016

Chiesi Farmaceutici SpA - Phase I, 2016

Chiesi Farmaceutici SpA - Preclinical, 2016

Chiesi Farmaceutici SpA - Unknown, 2016

Chiesi Farmaceutici SpA - Pipeline by Target, 2016

Chiesi Farmaceutici SpA - Pipeline by Route of Administration, 2016

Chiesi Farmaceutici SpA - Pipeline by Molecule Type, 2016

Chiesi Farmaceutici SpA - Pipeline Products by Mechanism of Action, 2016

Chiesi Farmaceutici SpA - Dormant Developmental Projects,2016

Chiesi Farmaceutici SpA - Discontinued Pipeline Products, 2016

Chiesi Farmaceutici SpA, Subsidiaries

List of Figures

Chiesi Farmaceutici SpA - Pipeline by Top 10 Indication, 2016

Chiesi Farmaceutici SpA - Pipeline by Stage of Development, 2016

Chiesi Farmaceutici SpA - Monotherapy Products in Pipeline, 2016

Chiesi Farmaceutici SpA - Combination Treatment Modalities in Pipeline, 2016

Chiesi Farmaceutici SpA - Out-Licensed Products in Pipeline, 2016

Chiesi Farmaceutici SpA - Pipeline by Top 10 Target, 2016

Chiesi Farmaceutici SpA - Pipeline by Route of Administration, 2016

Chiesi Farmaceutici SpA - Pipeline by Molecule Type, 2016

Chiesi Farmaceutici SpA - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Addex Therapeutics Ltd
- Bristol-Myers Squibb Company
- Eisai Co., Ltd.
- Eli Lilly and Company
- Heptares Therapeutics Limited
- Hua Medicine (Shanghai) Ltd.
- Johnson & Johnson
- Medgenics, Inc.
- Merz Pharma GmbH & Co. KgaA
- Sumitomo Dainippon Pharma Co., Ltd.
- Toray Industries, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll